Product Description
VPJ neither forms nor acts like an epicutaneous impermeable membrane; instead, it permeates throughout the SC interstices, allowing normal barrier recovery despite its occlusive properties. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/1564142/)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Nondrug
Route of Administration: Topical,Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Argentina | Australia | Bangladesh | Belgium | Brazil | Bulgaria | Canada | Chile | Colombia | Dominican Republic | Egypt | France | Germany | Greece | Hong Kong | India | Ireland | Italy | Lebanon | Malaysia | Mexico | New Zealand | Norway | Pakistan | Peru | Philippines | Portugal | Russia | South Africa | Spain | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | Uruguay | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
---|
Recent News Events
Date |
Type |
Title |
---|---|---|
07/09/2025 |
News Article |
Trax Retail Revolutionizes In-Store Execution for CPG Brands with New On-Device IR Technology, Powering the "Perfect Store" |
06/30/2025 |
News Article |
Dove Debuts Garden Tea Party-Inspired Body Care Collection Exclusively at Target |
06/24/2025 |
News Article |
Reality TV Stars Lindsay Hubbard and West Wilson Invite Mayo Skeptics to "Eat Your Words" in a Tasty Twist From Hellmann's Mayonnaise |
06/16/2025 |
News Article |
88RISING LAUNCHES "ROAD TO FAM - THE FINALE" WITH LEVI'SĀ® AND FAM STUDIOS BANGKOK TO EMPOWER THE NEXT GENERATION |